Header Artwork
Header Artwork



Polymer-based, Pre-filled Syringes designed to Minimize the Aggregation Risk of Sensitive Biodrugs

Published Date: June 16, 2022

Biopharmaceutical drugs offer new therapeutic solutions to numerous human diseases and conditions.

However, with this comes the risk of efficacy loss due to protein interactions potentially leading to immunogenicity impacting the patient’s safety and therapeutic outcome.

Terumo’s PLAJEX™ pre-fillable syringes (PFS) are designed to meet the needs of a wide variety of types of drugs including those requiring low reactive containers.

In this presentation, we will highlight some of the main values our PLAJEX™ PFS offer as well as the experience we have built over two decades with processing our primary containers on our own fill-and-finish lines in Japan.

Learn more about the presenter below.

Philippe Lauwers

Technology Development Director - Terumo

Philippe Lauwers is the Technology Development Director at Terumo Pharmaceutical Solutions (TPS), a division of Terumo. He has been active in the medical device and pharmaceutical packaging sector for the last 15 years with growing responsibilities in business development and technical roles. Philippe graduated in Biotechnology from the Ghent University, Belgium, and worked as a scientific researcher at the Catholic University of Leuven, Belgium. Upon obtaining an additional degree in Biomedical Engineering, he moved from an academic to an industrial environment. Philippe serves as an expert on the ISO Technical Committees 76 and 84 and is a volunteer with PDA.

Complete the form below to access the webinar.